Biomineralized Bacterial Outer Membrane Vesicles Potentiate Safe and Efficient Tumor Microenvironment Reprogramming for Anticancer Therapy
The DOI matches its Crossref record; 46 of the 48 references it cites were found in a registry or an index.
Abstract
The highly immunosuppressive tumor microenvironment (TME) in solid tumors often dampens the efficacy of immunotherapy. In this study, bacterial outer membrane vesicles (OMVs) are demonstrated as powerful immunostimulants for TME reprogramming. To overcome the obstacles of antibody‐dependent clearance and high toxicity induced by OMVs upon intravenous injection (a classic clinically relevant delivery mode), calcium phosphate (CaP) shells are employed to cover the surface of OMVs, which enables potent OMV‐based TME reprograming without side effects. Meanwhile, the pH‐sensitive CaP shells facilitate the neutralization of acidic TME, leading to highly beneficial M2‐to‐M1 polarization of macrophages for improved antitumor effect. Moreover, the outer shells can be integrated with functional components like folic acid or photosensitizer agents, which facilitates the use of the OMV‐based platform in combination therapies for a synergic therapeutic effect.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“OMVs with calcium phosphate (CaP) shells promoted cytotoxic T cell infiltration and M2 to M1 macrophage polarization, effectively improving the immunosuppressive TME [123] (Fig. 5H).”
From Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies (2022) · doi:10.1186/s13045-022-01273-9 · cites this paper as [123]
Citations
Cites
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Innate and adaptive immune cells in the tumor microenvironment
Gajewski, T. F., Schreiber, H., & Fu, Y.-X. (2013) · Nature Immunology · doi:10.1038/ni.2703 · Cited by 4,148
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Galon, J., & Bruni, D. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0007-y · Cited by 3,409
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164
Couzin-Frankel, J. (2013) · Science · doi:10.1126/science.342.6165.1432 · Cited by 2,051
Thommen, D. S., & Schumacher, T. N. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.012 · Cited by 1,299
Molecular tectonics in biomineralization and biomimetic materials chemistry
Mann, S. (1993) · Nature · doi:10.1038/365499a0 · Cited by 1,165
Rodell, C. B., Arlauckas, S. P., Cuccarese, M. F., Garris, C. S., Li, R., Ahmed, M. S., Kohler, R. H., Pittet, M. J., & Weissleder, R. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0236-8 · Cited by 1,099
Macrophage Regulation of Tumor Responses to Anticancer Therapies
De Palma, M., & Lewis, C. E. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.013 · Cited by 1,079
Research works printed but not linked: 1
- Schwechheimer C., 2015, Nat. Rev. Immunol., 13, 605
Cited by
Items 201–300 of 333
Zhang, R., Chang, L., Wang, J., Huang, M., Cui, Z., Li, S., Zhao, J., Yao, C., & Yang, D. (2024) · Science China Materials · doi:10.1007/s40843-024-3094-9 · Cited by 14
“Second, the direct intravenous injection of OMVs led to severe toxic side effects, such as systemic cytokine storm and specific immune clearance [18,19].”
Self-citationMicrobe-host interactions: structure and functions of Gram-negative bacterial membrane vesicles
Xiao, M., Li, G., & Yang, H. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1225513 · Cited by 14
Wang, Z., Li, M., Li, W., He, L., Wang, L., Cai, K., Zhao, X., Chen, Y., & Li, D. (2025) · Advanced Science · doi:10.1002/advs.202415379 · Cited by 14
Wang, R., Li, W., Cao, H., & Zhang, L. (2025) · Biology · doi:10.3390/biology14030243 · Cited by 17
“Through precise modifications of their surface proteins and polysaccharide structures, they can specifically interact with tumor cells or components of the tumor extracellular matrix [167,171].”
Uddin, M. A., Yu, H., Wang, L., Sheng, Y., Mehmood, S., Amin, B. U., & Liang, R. (2021) · Materials Today Communications · doi:10.1016/j.mtcomm.2021.103107 · Cited by 13
Zhuang, H., Wang, R., Qi, Y., Liu, Y., Xiong, H., & Yao, J. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.07.036 · Cited by 12
Innovative design of bacterial outer membrane vesicles for vaccine development
Cheng, Q., Niu, G., He, Y., Zhu, Y., Kang, Y., Zhang, Z., & Ji, X. (2025) · Nano Today · doi:10.1016/j.nantod.2025.102650 · Cited by 12
Feng, C., Wang, Q., Xiao, S., Chen, B., Fan, R., Han, B. R., Zou, B., & Guo, G. F. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202511828 · Cited by 15
Zhang, Z., Tu, J., Kuang, X., Shi, M., Zhang, Y., Li, H., Huang, J., Wang, L., & Yuan, H.-J. (2023) · New Journal of Chemistry · doi:10.1039/d3nj03511e · Cited by 13
Boosting Checkpoint Immunotherapy with Biomimetic Nanodrug Delivery Systems
Chen, W., Tang, C., Chen, G., Li, J., Li, N., Zhang, H., Di, L., & Wang, R. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202304284 · Cited by 15
Shen, H., Chen, S., Zhang, C., Liu, T., Tao, Y., Hu, L. T., & Yang, K. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.151837 · Cited by 12
Zhang, Y., Liu, X., & Wu, G. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1648379 · Cited by 14
Outer membrane vesicles: Versatile nanocarriers for therapeutic delivery and immune modulation
Yang, J., Wang, T., Zheng, Y., Wei, Y., Tao, J., Chen, Z., & Qi, J. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.01.033 · Cited by 11
“…enhances safety but also facilitates dissolution triggered by acidic tumor tissue, neutralizes the acidic TME, prevents OMV leakage into healthy tissues, and promotes macrophage polarization from anti-inflammatory M2 to pro-inflammatory M1 phenotypes, thereby enhancing antitumor efficacy 20,22 .”
Engineered Bacterial Biomaterials for Augmenting Adoptive Immune Cell Therapy Against Solid Tumors
Zhu, C., Sun, Z., Wu, Q., Wang, F., Zhang, L. L., Wang, W., Ding, Y., & Li, H. (2026) · Advanced Materials · doi:10.1002/adma.202522140 · Cited by 11
Zhang, X., Wu, J., Zhang, Z., Liu, C., & Xie, J. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.121559 · Cited by 10
“[83, 89, 90] Appropriate OMV stimulation can even enhance immunity against other diseases [91] , and OMV-targeting drugs are critical for the control of gram-negative bacterial infections.”
Wang, F., Fan, J., Pan, W., Liu, M., Wang, J., Wei, X., Xian, Y., Chen, S., Cui, C., Chen, Y., et al. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.10.012 · Cited by 14
Self-citationThe Immune Microenvironment in Liver Cancer: From Analysis to Targeting
Lan, J., Li, H., Xue, J., Duan, Y., Sun, J., & Niu, M. (2025) · Advanced Science · doi:10.1002/advs.202518487 · Cited by 11
Bacteria−Based Synergistic Therapy in the Backdrop of Synthetic Biology
Bao, Y., Cheng, Y., Liu, W., Luo, W., Zhou, P., & Qian, D. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.845346 · Cited by 10
“Nevertheless, the bacteria colonized in tumor hypoxic areas are expected to remold TME and improve immune response (52).”
BackgroundYan, Y., Zhang, L., & Feng, L. (2025) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2025.102452 · Cited by 13
Bioengineered therapeutic systems for improving antitumor immunity
Cao, Y., Yan, W., Yi, W., Yin, Q., & Li, Y. (2024) · National Science Review · doi:10.1093/nsr/nwae404 · Cited by 10
“The means currently used to modify organisms include biological, chemical and physical dimensions as well as their integrations [25 ,106 ,119 ].”
Strategic Advances in Targeted Delivery Carriers for Therapeutic Cancer Vaccines
Wu, J., Liang, J., Zhang, Y., Dong, C., Tan, D., Wang, H., Zheng, Y., & He, Q. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146879 · Cited by 11
Engineering biomimetic bacteria membrane-coated nanoparticles: an emerging anti-infection platform
Hakimi, F., Almasi, F., Etezadi, H., Salarilak, L., Vosough, M., Karimkhanlooei, G., Esmaeilzadeh, K., Sesma, J. Z., Maleki, H. H., Turner, R. J., et al. (2025) · Materials Horizons · doi:10.1039/d5mh00918a · Cited by 12
Bacterial outer membrane vesicles: a smart platform for biomedical applications
Wang, J., Liu, Q., Huang, F., Wang, S., Wu, C., Yang, C., Huang, S., Liang, Y., & Pan, X. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-025-02645-7 · Cited by 10
“Parallel biochemical approaches, including EDTA extraction or calcium phosphate surface mineralization, have also demonstrated efficacy in suppressing inflammatory responses and enhancing overall biocompatibility [76, 128].”
Self-citationZhang, Q., Ma, R., Chen, S., Cao, K., Wang, Y., & Xu, Z.-R. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.01.041 · Cited by 9
Qin, X., Xu, H., Zhao, S., Kong, L., Yang, C., & Zhang, Z. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.149224 · Cited by 9
Lathia, J. D., & Watson, D. C. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-4055-5_14 · Cited by 9
Yan, L., Wu, F., Jiao, J., Maimaiti, A., Li, Y., Shao, L., Liang, Q., Xiong, X., & Qin, Z. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s491473 · Cited by 8
“13 Mukeng Hong et al discovered that bacteria within the intestinal microbiota could modulate the inflammatory process of osteoarthritis through the secretion of bacterial vesicles, thus participating in the regulatory mechanisms underlying osteoarthritis.”
InfluentialMetastatic hepatic carcinoma: Mechanisms, emerging therapeutics, and future perspectives
Zhou, J., Sui, Y., & chen, Z. (2025) · iScience · doi:10.1016/j.isci.2025.112902 · Cited by 8
Bacterial Foreignization Nanosystem Elicits Multi‐Phenotypic T Cells for Antitumor Immunity
Zhuang, W., Xue, W., Liang, C., Liu, P., Lei, Y., He, J., Cheng, R., Nie, W., Wang, J., Tang, J., et al. (2025) · Advanced Science · doi:10.1002/advs.202504155 · Cited by 8
Self-citationEngineering strategies and biomedical applications of bacterial extracellular vesicles.
Liang, X., Li, Q., Zheng, L., & Situ, B. (2025) · PubMed Central · doi:10.12336/bmt.24.00032 · Cited by 10
“11,26,51 For example, Qing et al. 11 created indocyanine green-loaded BEVs to enhance the PTT effect against the 4T1 tumour, resulting in completely suppressed tumour growth.”
InfluentialBioengineering modification and application of bacterial outer membrane vesicles
Wen, Y., Si, Y., Jia, X., Han, Z., Zhou, Z., Wu, Z., & Zheng, J. (2026) · International Journal of Medical Sciences · doi:10.7150/ijms.116432 · Cited by 8
“Additionally, the outer shell of OMVs can be functionalized with components such as folic acid to promote targeted tumor therapy [88] .”
Wei, Y., Zhang, Z., Xue, T., Lin, Z., Chen, X., Tian, Y., Li, Y., Jing, Z., Fang, W., Fang, T., et al. (2024) · ACS Synthetic Biology · doi:10.1021/acssynbio.3c00569 · Cited by 9
Sharif, E., Nezafat, N., & Mohit, E. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113283 · Cited by 8
Bacterial Expression of Promelittin for Safe and Effective Tumor Therapy
Xu, W., Chen, H., Duan, Y., Ge, D., Ren, D., Zhao, S., Liu, Y., Ma, L., & Zhang, C. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c11457 · Cited by 8
Interaction between intestinal flora and gastric cancer in tumor microenvironment
Yang, M. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1402483 · Cited by 8
Sun, M., Wu, Y., Chen, Z., Zhang, B., Liu, X., Ouyang, P., Chen, P., Chen, L., He, Z., Han, T., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62543-x · Cited by 10
Ding, G., Wen, L., He, J., Xin, Y., Feng, F., Wang, E., Li, D., Shan, G., & Wang, J. (2025) · ACS Nano · doi:10.1021/acsnano.5c10494 · Cited by 7
Self-citationFan, Q., Li, J., Qu, X., Liu, Y., Ren, Y., Zhang, J., Wen, K., Dong, Z., & Wang, L. (2026) · ACS Nano · doi:10.1021/acsnano.5c16031 · Cited by 7
Zhao, H., Ning, Y., Liu, Y., Tan, B. S. N., Liang, Y., & Zhao, Y. (2026) · ACS Nano · doi:10.1021/acsnano.5c20888 · Cited by 8
Wang, R., Li, X., Fu, G., Hu, M., Dou, H., Zhang, G., Pengshun, Q., Mao, J., Zhu, T., & Cao, Q. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.154170 · Cited by 7
Liu, J., Wang, T., Zhou, Y., Wang, X., Ma, B., Su, C., & Duan, X. (2025) · Journal of Materials Chemistry B · doi:10.1039/d4tb01899k · Cited by 7
Biomimetic nanosystems based on cell membranes (BNCMs) for cancer immunotherapy
Wang, Y., Huang, X., Wu, Q., & Gong, C. (2024) · MedComm – Biomaterials and Applications · doi:10.1002/mba2.106 · Cited by 8
Xiao, Z., Yuan, J., Wu, Q., Qin, J., Liu, Y., Zhang, S., Sun, B., Dai, R., Zhang, P., Shao, N., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.11.005 · Cited by 7
“It has been demonstrated that OMVs can activate the NLRP3 inflammatory vesicle signalling pathway via Caspase-11, upregulate IL-1 ß secretion 20 , and promote T cell maturation and its mediated adaptive immune response 21,22 .”
Chen, L., Qiao, G., Liu, F., Cheng, K., & Zhao, X. (2025) · Science China Chemistry · doi:10.1007/s11426-025-3114-6 · Cited by 6
Bacterial Outer Membrane Vesicles in Potentiating Cancer Vaccines: Progress and Prospects
Zhang, J., Shao, T., Qu, F., Bai, C., Li, S., Gao, P., Li, W., Cheng, K., Zhao, X., & Fan, Z. (2026) · Advanced Science · doi:10.1002/advs.202521684 · Cited by 8
“…as calcium phosphate (CaP) shell coating— can mitigate systemic toxicity, enhance circulation stability, and introduce stimuli-responsive properties, while simultaneously promoting macrophage reprogramming toward an antitumor phenotype and enabling multifunctional therapeutic integration [ 25 ].”
Bacterial Extracellular Vesicles in Biomedical Research and Clinical Translation
Arce‐Rodríguez, A., Noya, J. D. L. P., & Acuña, J. M. B. (2026) · Microbial Biotechnology · doi:10.1111/1751-7915.70350 · Cited by 7
“Accordingly, Qing et al. (2020) functionalized OMVs with the photosensitizer ICG and decorated their surface with folic acid (FA).”
Zhang, X., Li, M., Tang, Y., Zheng, M., & Liang, X. (2024) · Biomaterials Science · doi:10.1039/d4bm00366g · Cited by 6
Bawali, P., Brahma, A., Rana, S. R., Pal, A., & Bhattacharyya, A. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1444242 · Cited by 7
Cell Membrane-Camouflaged Nanoparticles: A Promising Biomimetic Platform for Tumor Therapy
Lyu, C., Wang, W., Yang, Y., Guo, P., Li, F., & Wei, W. (2025) · JOURNAL OF CHEMICAL ENGINEERING OF JAPAN · doi:10.1080/00219592.2024.2434611 · Cited by 6
Self-citationTan, Q., Yang, Z., Bu, S., Chen, J., Chen, W., Geng, W., Huang, Q., Duan, L., Guo, M., Wu, Y., et al. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.142497 · Cited by 7
Sharif, E., Mobasheri, T., & Mohit, E. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127088 · Cited by 5
Li, J., Zhang, Y., Wang, W., Gong, Y., Zhou, Y., & Yang, Y. (2026) · ACS Nano · doi:10.1021/acsnano.5c14053 · Cited by 5
Li, L., Xue Qi, L. I., Zhang, J. X., Wu, Q. Y., Chen, P. P., Ruan, X. Z., & Ma, K. L. (2026) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70234 · Cited by 5
Tang, M., Lv, W., Gao, X., Xu, C., Zhang, T., Liang, B., Zhao, X., Liao, H., Du, C., Li, X., et al. (2026) · ACS Nano · doi:10.1021/acsnano.5c14341 · Cited by 6
Self-citationWang, J., Wang, S., Wang, Y., Zhang, T., & Zhang, X. (2026) · Theranostics · doi:10.7150/thno.132287 · Cited by 5
“OMVs can also convert immune “cold” tumors into “hot” tumors by regulating macrophage metabolism [102], inducing apoptosis-and autophagy-mediated immunogenic cell death [103], and promoting macrophage repolarization from the M2 to the M1 phenotype [104].”
Self-citationPathogen Recognition-Driven Dendritic Cell-Specific Gene Silencing and Editing
Li, M., Zhou, H., Wu, N., Deng, W., Wang, D., Sun, X., Liu, H., Tian, Z., & Wang, Y. (2023) · Nano Letters · doi:10.1021/acs.nanolett.3c00015 · Cited by 5
Hybrid Bacteria System with Nanomaterials for Tumor Therapy
Zhang, Q., Ma, X., & Zhao, X. (2023) · Advanced NanoBiomed Research · doi:10.1002/anbr.202300003 · Cited by 6
Zhang, Z., Cui, H., Zhang, T., Zhang, M., Wu, L., Zhang, X., Zhou, X., Li, X., Zhai, Y., Lu, Z., et al. (2023) · Materials & Design · doi:10.1016/j.matdes.2023.112067 · Cited by 5
Zhao, S., Xu, W., Zeng, W., He, S., Luo, X., Ge, D., Duan, Y., Han, R., Chen, C., Yang, Y., et al. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.114707 · Cited by 4
Yin, R., Jin, H., Yu, J. X., Shao, L., & Yu, X. (2025) · Cancer Nanotechnology · doi:10.1186/s12645-025-00332-3 · Cited by 4
“Gram-negative bacteria can produce nanoscale spherical outer membrane vesicles (OMVs) with immune-stimulating capabilities for tumor treatment during bacterial growth (Qing et al. 2020).”
The application of AI-driven and engineered intratumoral microbes in cancer therapy
Guo, Y., Yu, R., Wang, Z., Chang, J., & Han, L. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07546-4 · Cited by 4
“Outer membrane vesicles (OMVs), potent immuno-stimulatory agents for TME reprogramming, were engineered with calcium phosphate (CaP) shells by Qing et al. [102].”
Cheng, X., Luo, Z., Yin, Y., Fan, D., Xie, R., Fang, Y., Liu, X., Xiong, D., Liu, W., Wegner, S. V., et al. (2026) · Smart Molecules · doi:10.1002/smo2.70039 · Cited by 4
Nanotechnologies for Enhancing Anti-Tumor Therapies
Ning, J., Zhang, G., Balash, M., Hong, L., & Zhu, L. (2022) · OpenNano · doi:10.1016/j.onano.2022.100042 · Cited by 4
Self-citationBai, S., Xu, S., Lan, Y., Lu, Z., Liu, L., Song, W., Wu, R., Ma, F., Chen, H., Zeng, Y., et al. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202414417 · Cited by 7
Lei, T., Jiang, Z., Nan, J., Fan, H., Yang, J., Wang, Y., Hua, L., Hu, Q., & Hu, Y. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.160854 · Cited by 5
Jorge, G. P., Gontijo, M. T. P., Silva, M. F. E., Liszbinski, R. B., Tavares, R. S. N., Negrão, C. V. Z. D. V., Grundmann, C. O., Goes, I. C. R. D. S., Coser, L. D. O., Bilsland, E., et al. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c00933 · Cited by 3
Chen, H., Xie, Q., Cai, J., Xin, Q., Yao, W., Xu, H., & Zhou, Z. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1585809 · Cited by 3
Wang, W., Song, A., Pu, F., Zhang, Y., Ren, J., & Qu, X. (2025) · Chemical Science · doi:10.1039/d5sc07867a · Cited by 3
“25,39,40 We evaluated the in vivo toxicity by intravenously injecting Kunming mice with normal saline, OMVs, and OHH, respectively.”
Li, X., Wu, X., Su, W., Filipczak, N., Yalamarty, S. S. K., Jiang, W., Tao, D., Yang, S., & Zhang, J. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18020268 · Cited by 3
Engineering strategies of bacterial outer membrane vesicles for enhancing tumor immunotherapy
Yu, Z., Ma, Y., Guo, Q., Liu, H., Li, Z., & Zhang, J. (2026) · Nanoscale · doi:10.1039/d6nr01038e · Cited by 3
Zhang, Y., Chen, P., Wen, W., Qian, X., He, T., Fu, L., Lin, J., & Huang, P. (2026) · ACS Nano · doi:10.1021/acsnano.5c19115 · Cited by 3
Galen, J. E., & Pham, T. (2022) · Medical Research Archives · doi:10.18103/mra.v10i7.2895 · Cited by 3
MnO 2 -mineralized milk exosomes as a novel nanoplatform for glutathione detection
Wang, X., Wu, X. M., Shen, J., Zhao, X., Gao, P., Zhou, W., & An, W. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb01662a · Cited by 3
Bai, J., Wang, M., Luo, Y., Duan, B., Yang, Y., Fu, Y., Li, S., Yang, Z., Zheng, P., Yu, T., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03471-2 · Cited by 4
“It was reported that bacterial membrane vesicles can interfere with the growth of implanted tumor in mice through intravenous administration, due to its tumor -targeting ability and immunoregulative effects in TME [27, 28].”
Bioengineered bacterial vesicles for optoacoustics-guided phototherapy
Gujrati, V., & Ntziachristos, V. (2021) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2021.06.030 · Cited by 3
In Situ Application of Berberine-Loaded Liposomes on the Treatment of Osteomyelitis
Wang, S., Zhao, T., Sun, Y., Li, S., Lu, D., Qiu, M., Yan, B., Yang, J., Shao, Z., Yin, Y., et al. (2025) · ACS Omega · doi:10.1021/acsomega.4c11198 · Cited by 2
Self-citationProbiotics lead to a new frontier in tumor fighting: tumor vaccines based on probiotics
Ma, T., Liang, Q., Zhou, Z., & Shen, J. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07426-x · Cited by 3
In vivo chemogenetic RNA editing of macrophages by bioengineered viruses for sepsis treatment
Xi, W., Xu, Y., Bao, W., Ding, Z., Hu, X., Yang, J., Yan, X., & Ping, Y. (2025) · Nature Communications · doi:10.1038/s41467-025-67655-y · Cited by 2
“Following 24 h of i.p. administration, we found the distribution of indocyanine green (ICG)-labeled Lenti@Cap-FAs nanoparticles were primarily located in the cecum of the septic mice where FA receptors overexpressed M1 macrophages accumulate 11 .”
InfluentialZhang, K., Sun, X., Ji, T., Shen, X., Li, Y., Zhao, H., Yang, X., Li, H., & Huang, W. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102754 · Cited by 3
Gu, Z., Zhang, M., Shen, F., Chen, J., Gu, Y., Gong, Y., Xue, Q., Zhou, H., Liu, Y., Shao, S., et al. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s582600 · Cited by 2
“106 Moreover, in the PEG/Se@OMV-CD47nb mentioned above, the surface PEG/Se layer endows the nanoparticles with radiation-triggered controlled release of OMV-CD47nb, also mitigating the side effects observed from intravenous injection of naked OMVs.”
Chen, F., Xue, Y., Ma, X., Chen, L., Shao, Z., Sun, H., Mou, H., Wang, F., Li, Z., Shen, Y., et al. (2026) · Advanced Science · doi:10.1002/advs.202517369 · Cited by 2
“Engineered outer membrane vesicles (OMVs) from hypoendotoxic Escherichia coli BL21 ( ΔmsbB) intrinsically favor monocyte/macrophage uptake via Toll-like receptor 4 (TLR4), offering a natural advantage over synthetic nanoparticles for myeloid targeting [ 48–50 ].”
Self-citationSystemic health impact of cancer-associated extracellular vesicles and particles
Wang, G., Lucotti, S., Bojmar, L., Tobias, G. C., Piszczatowski, R. T., Dror, S., Zhang, H., & Lyden, D. C. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-026-00952-w · Cited by 2
“…metastatic PDAC, for which a phase I trial using engineered human bone marrow MSC-derived EVPs targeting KRAS(G12D) has demonstrated a favorable safety profile in humans and in combination with ICB in preclinical models 248 , suggesting that this might be a promising combinatorial strategy.”
Wang, Y., Li, F., Wang, S., Meng, J., Zhang, X., & Wei, W. (2024) · Particuology · doi:10.1016/j.partic.2024.03.005 · Cited by 2
Self-citationShi, X., Xu, L., Liu, B., Zhang, J., Zhai, W., Luan, Y., Zhou, J., & Zhou, X. (2025) · ChemistrySelect · doi:10.1002/slct.202403165 · Cited by 2
Biomimetic Nucleic Acid Drug Delivery Systems for Relieving Tumor Immunosuppressive Microenvironment
Yan, W., Cao, Y., Yin, Q., & Li, Y. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16081028 · Cited by 1
“Tumor microenvironment-sensitive linker-conjugated albumin or biomimetic mineralization on OMVs reduced side effects and mononuclear phagocyte system clearance [100,101].”
BackgroundImmunogenicity of neoantigens: From CAR-T cell to various vaccines
Davodabadi, F., Arabpour, J., Goleij, P., Mohammadi, E., Taheri, M., Sethi, G., Dua, K., & Sarhadi, M. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125924 · Cited by 1
Hou, T., Shen, Z., Chen, W., Song, Y., Yan, Y.-Y., Luo, Z., Li, Y., Shan, Y.-T., Li, R., Shen, T.-Y., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.165764 · Cited by 1
Outer membrane vesicles as novel therapeutics for heart repair
Shen, M., Zhu, D., Li, T., Wei, S., Wang, X., & Zheng, M. (2025) · Extracellular Vesicle · doi:10.1016/j.vesic.2025.100092 · Cited by 1
Biomimetic hybrid vesicle nanoplatform with Pt-BaTiO3 for sonodynamic-immunotherapy of glioblastoma
Li, B., Zhao, L., Han, Z., Tang, Z., Qiu, J., Zhao, R., Feng, B., Zhang, Q., Wang, D., Gao, Z., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.167363 · Cited by 5
Ma, A., Wang, C., Wang, Y., Zhang, G., Guo, Z., Wu, L., Li, X., Wang, Y., Wang, Y., & Yang, X. (2025) · Biomaterials Science · doi:10.1039/d5bm01457c · Cited by 1
Zhang, Y., Chen, J., Song, Q., Zhang, Y., Xu, H., Ye, W., Wang, Y., Yu, X., & Li, L. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.5c01282 · Cited by 1
Dai, H., Wang, Y., Chen, X., Zhu, J., Wang, H., Cui, D., Wu, H., Huang, G., Luo, R., Yu, J., et al. (2026) · Nanoscale · doi:10.1039/d5nr04621a · Cited by 1
Kraan, H., van der Geest, A., Oosterhoff, D., Kruiswijk, C. P., & Soema, P. C. (2026) · Vaccines · doi:10.3390/vaccines14070575 · Cited by 1
“Compared to these approaches, OMV-based vaccines offer a non-replicating and inherently immunostimulatory platform that can be rapidly engineered and does not require live pathogens or viral vectors [24–26].”
Bacteria mediated tumor therapy recent advances challenges and future perspectives
Mao, W., & Deng, C. (2026) · Discover Oncology · doi:10.1007/s12672-026-05611-y · Cited by 1
“These abnormally proliferative tumor cells seize nutrients from normal tissues, disrupt physiological organ functions, and eventually induce diverse clinical symptoms and even patient death [32, 33].”
Advances and projects of immunomodulatory biomaterials used for immunotherapy
Frumento, D., & Patra, N. (2026) · Holistic Integrative Oncology · doi:10.1007/s44178-026-00296-3 · Cited by 1
“Furthermore, bacterial outer membrane vesicles (OMVs) represent another potent immunostimulatory membrane-derived biomaterial capable of inducing M1 macrophage polarization and promoting tumour T cell infiltration [165].”
Pour Messiaen: se dónde está, pero aún me pregunto quién es
Bermúdez, S. M. (2008) · Scherzo: revista de música
A Novel Nanomedicine System TAR‐AuNSs/Dox for the Treatment of Drug‐Resistant Lymphoma
Ouyang, S., Tang, Y., & Cao, Y. (2022) · Journal of Nanomaterials · doi:10.1155/2022/5084672
Scientific trends and knowledge structures of exosomes from macrophages: a bibliometric analysisPreprint
Liu, Y., Zheng, B., Zhong, Y., & Liu, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1671439/v1
Role of Animal Models in the Development of Bacteria-Based Live Therapeutics to Fight Cancer
Tata, K., Ramadevi, S., Shelin, R., & Meenakshi, S. (2022) · Handbook of Animal Models and its Uses in Cancer Research · doi:10.1007/978-981-19-1282-5_7-1
Role of Animal Models in the Development of Bacteria-Based Live Therapeutics to Fight Cancer
Tata, K., Ramadevi, S., Shelin, R., & Meenakshi, S. (2023) · Handbook of Animal Models and its Uses in Cancer Research · doi:10.1007/978-981-19-3824-5_7
Metadata
- Authors
- Qing, S., Lyu, C., Zhu, L., Pan, C., Wang, S., Li, F., Wang, J., Yue, H., Gao, X., Jia, R., Wei, W., & Ma, G.
- Affiliations
- Chinese Academy of Sciences (CN)
- State Key Laboratory of Pathogen and Biosecurity Beijing Institute of Biotechnology No. 20 Dongda Street Beijing 100071 P. R. China
- Shanghai Jiao Tong University (CN)
- Corresponding author
- Wei, Wei
- Ma, Guanghui
- ORCID
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2020-10-05
- Volume
- 32
- Issue
- 47
- Pages
- e2002085-e2002085
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W3090405704
- Cited by
- 309
- References
- 48
- Citations by year
- 2026: 31 · 2025: 72 · 2024: 75 · 2023: 56 · 2022: 42 · 2021: 31 · 2020: 1
- FWCI
- 10.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Advanced Materials (publishedVersion)
- PubMed (publishedVersion)
- Institute of Process Engineering, CAS Institutional Repository (submittedVersion)
- Funders
- National Natural Science Foundation of China (21821005)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- bacterial outer membrane vesicles, biomineralization, tumor microenvironment reprogramming, immunosuppression, M2 to M1 macrophage polarization, pH-responsive drug delivery, folic acid, photosensitizers, combination therapy, intravenous injection
- MeSH terms
- Extracellular Vesicles, Biomineralization, Bacterial Outer Membrane, Adjuvants, Immunologic, Immunotherapy, Macrophages, Safety, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.